[Clinical and immunological characteristics of HIV-positive AIDS in children in Northern Israel]

E Kedem1, A Etzioni, E Shahar

  • 1Institute of Immunology, Allergy and AIDS and Dept. of Pediatrics A, Rambam Medical Center and B. Rappaport Faculty of Medicine, The Technion, Haifa.

Harefuah
|November 10, 2004
PubMed

Insights

Early antiretroviral treatment and supportive care significantly improve outcomes for children with HIV/AIDS. This approach stabilizes immune function and enhances quality of life, contrasting with more rapidly progressive disease patterns in literature.

Area of Science:

  • Pediatric infectious diseases
  • Immunology
  • Public health

Context:

  • Vertical transmission of Human Immunodeficiency Virus (HIV) remains a significant concern.
  • Management of pediatric Acquired Immunodeficiency Syndrome (AIDS) requires comprehensive care.
  • Zidovudine prophylaxis in pregnant, HIV-carrier mothers shows potential in preventing vertical transmission.

Purpose:

  • To evaluate the clinical status and treatment outcomes of children with HIV/AIDS.
  • To assess the impact of combined antiretroviral therapy and opportunistic infection prophylaxis.
  • To investigate factors contributing to disease progression and clinical well-being.

Summary:

  • Eleven children with HIV/AIDS, infected via vertical transmission, were treated with a combination of 2-3 antiretroviral drugs.
  • 8/11 children received prophylactic treatment for opportunistic infections, and 8/11 are clinically well.
  • Despite moderate to severe immunodeficiency, CD4+ cell counts remained stable over an average 28-month follow-up, suggesting treatment efficacy.

Impact:

  • Aggressive medical and supportive treatment, including regular follow-up and family engagement, improves clinical condition and quality of life in pediatric HIV/AIDS.
  • The study highlights a lower rate of rapidly progressive disease (60%) compared to literature (10-15%) in this cohort, potentially due to early and comprehensive intervention.
  • Effective management strategies can lead to stable disease markers and improved patient outcomes in pediatric HIV/AIDS care.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...